Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.99 is 646% above its 5-year average of 1.07, around the middle of its 5-year range (0.00–24.40).
As of the fiscal period ended Tuesday, June 30, 2026. 273.75% above its 12-month average of 2.14.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.99.
CURRENT RATIO
7.99
CURRENT RATIO AVG TTM
2.14
CURRENT RATIO AVG 3Y
0.19
CURRENT RATIO AVG 5Y
1.07
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+273.75%
CURRENT VS 3Y AVG
+4214.82%
CURRENT VS 5Y AVG
+646.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.38
median of 612 covered companies
CURRENT VS SECTOR MEDIAN
+136.61%
vs the sector median at left
Aspire Biopharma Holdings, Inc.
Market Cap
$1.03M
Current Ratio
7.99
TTM Avg
2.14
3Y Avg
0.19
5Y Avg
1.07
Market Cap
$1.10M
Current Ratio
3.86
TTM Avg
3.42
3Y Avg
2.60
5Y Avg
2.60
Market Cap
$898311.00
Current Ratio
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$1.18M
Current Ratio
0.66
TTM Avg
1.48
3Y Avg
0.74
5Y Avg
0.53
Market Cap
$844393.00
Current Ratio
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
Market Cap
$838015.00
Current Ratio
4.64
TTM Avg
5.46
3Y Avg
4.98
5Y Avg
8.82
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.03M | 7.99 | 2.14 | 0.19 | 1.07 |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | 4.31 | 1.47 | 1.08 | 7.17 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | 3.86 | 3.42 | 2.60 | 2.60 |
| Bone Biologics Corporation (BBLG)vs › | $898311.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | 0.56 | 0.67 | 0.76 | 1.51 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | 0.66 | 1.48 | 0.74 | 0.53 |
| GlucoTrack, Inc. (GCTK)vs › | $869976.00 | 0.46 | 3.06 | 2.92 | 4.37 |
| Decoy Therapeutics Inc. (DCOY)vs › | $844393.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838015.00 | 4.64 | 5.46 | 4.98 | 8.82 |
| Genprex, Inc. (GNPX)vs › | $1.33M | 6.77 | 2.33 | 3.65 | 17.91 |
Current Ratio
7.99
Quick Ratio
7.81
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.99 |
| 2026-03-31 | 2.26 |
| 2025-12-31 | 0.17 |
| 2025-09-30 | 0.17 |
| 2025-06-30 | 0.09 |
| 2025-03-31 | 0.22 |
| 2024-12-31 | 0.09 |
| 2024-09-30 | 0.01 |
| 2024-06-30 | 0.06 |
| 2024-03-31 | 0.02 |
| 2023-12-31 | 0.20 |
| 2023-09-30 | 0.80 |
| 2023-06-30 | 1.92 |
| 2023-03-31 | 2.54 |
| 2022-12-31 | 3.62 |
| 2022-09-30 | 6.08 |
| 2022-06-30 | 8.25 |
| 2022-03-31 | 24.40 |
| 2021-12-31 | 1.00 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
